Insider · CIK 0001565916
Hubert L Allen
officer
Files at ABT (ABBOTT LABORATORIES). First filing Oct 23, 2024, latest Jan 31, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $43M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ABT: ABBOTT LABORATORIES
ABTOct 9, 2026 · close 99.60
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | ABBOTT LABORATORIES | $24M 189,788 shares | -60% | +15% from low-1% from high | |
| 15Weak | ABBOTT LABORATORIES | $18M 157,421 shares | -46% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | ABT ABBOTT LABORATORIES | FTax withholding Common shares without par value | -8,382 | $135.87 | $1.1M | 191,899 | Mar 4, 2025 |
| Feb 25, 2025 | ABT ABBOTT LABORATORIES | AGrant or award Common shares without par value | +15,475 | $0.00 | $0 | 200,281 | Feb 27, 2025 |
| Feb 25, 2025 | ABT ABBOTT LABORATORIES | AGrant or award Option (right to buy)derivative | +57,635 | $0.00 | $0 | 57,635 | Feb 27, 2025 |
| Jan 29, 2025 | ABT ABBOTT LABORATORIES | MOption exercise Common shares without par value | +131,360 | $38.40 | $5.0M | 316,166 | Jan 31, 2025 |
| Jan 29, 2025 | ABT ABBOTT LABORATORIES | SOpen-market sale Common shares without par value | -131,360 | $128.35 | $17M | 184,806 | Jan 31, 2025 |
| Jan 30, 2025 | ABT ABBOTT LABORATORIES | MOption exercise Common shares without par value | +58,428 | $38.40 | $2.2M | 243,234 | Jan 31, 2025 |
| Jan 30, 2025 | ABT ABBOTT LABORATORIES | SOpen-market sale Common shares without par value | -58,428 | $128.07 | $7.5M | 184,806 | Jan 31, 2025 |
| Jan 29, 2025 | ABT ABBOTT LABORATORIES | MOption exercise Option (right to buy)derivative | -131,360 | $0.00 | $0 | 58,428 | Jan 31, 2025 |
| Jan 30, 2025 | ABT ABBOTT LABORATORIES | MOption exercise Option (right to buy)derivative | -58,428 | $0.00 | $0 | 0 | Jan 31, 2025 |
| Oct 21, 2024 | ABT ABBOTT LABORATORIES | MOption exercise Common shares without par value10b5-1 | +157,421 | $47.00 | $7.4M | 342,227 | Oct 23, 2024 |
| Oct 21, 2024 | ABT ABBOTT LABORATORIES | SOpen-market sale Common shares without par value10b5-1 | -1,249 | $118.81 | $148k | 340,978 | Oct 23, 2024 |
| Oct 21, 2024 | ABT ABBOTT LABORATORIES | SOpen-market sale Common shares without par value10b5-1 | -5,901 | $118.15 | $697k | 335,077 | Oct 23, 2024 |
| Oct 21, 2024 | ABT ABBOTT LABORATORIES | SOpen-market sale Common shares without par value10b5-1 | -150,271 | $116.98 | $18M | 184,806 | Oct 23, 2024 |
| Oct 21, 2024 | ABT ABBOTT LABORATORIES | MOption exercise Option (right to buy)derivative10b5-1 | -157,421 | $0.00 | $0 | 0 | Oct 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.